Cargando…
Teriparatide Associated Late Hypercalcemia: A Report of Two Cases and Literature Review
INTRODUCTION: Teriparatide, recombinant human parathyroid hormone (1–34), is a safe and usually well-tolerated medication. We describe two cases of late-onset hypercalcemia associated with teriparatide use and report current evidence of hypercalcemia during the treatment with PTH analogs. CASE REPOR...
Autores principales: | Milosavljevic, Jovan, Thomas, Asha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Greater Baltimore Medical Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195114/ https://www.ncbi.nlm.nih.gov/pubmed/35711860 http://dx.doi.org/10.55729/2000-9666.1010 |
Ejemplares similares
-
MON-358 Hypercalcemia During Teriparatide Therapy
por: Milosavljevic, Jovan, et al.
Publicado: (2020) -
Severe hypercalcemia due to teriparatide
por: Karatoprak, Cumali, et al.
Publicado: (2012) -
Teriparatide Induced Delayed Persistent Hypercalcemia
por: Thiruchelvam, Nirosshan, et al.
Publicado: (2014) -
Teriparatide Treatment for Hypercalcemia Associated With Adynamic Bone Disease
por: Peugh, Jennifer, et al.
Publicado: (2019) -
Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review
por: Zahedi, Maryam, et al.
Publicado: (2021)